已收盤 11-19 16:00:00 美东时间
0.000
0.00%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Ambac(现更名为Octave Specialty Group)业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **整体业绩表现:** - 净亏损从持续经营业务:2025年第三季度亏损3200万美元(每股0.67美元),2024年同期亏损1800万美元(每股0.43美元),亏损幅度扩大 - 调整后EBITDA:2025年亏损300万美元,2024年盈利不到200万美元,由盈转亏 **分业务板块表现:** - 保险分销业务收入:2025年第三季度4300万美元,同比增长80%,其中有机增长40% - 保险分销调整后EBITDA:股东层
11-12 12:30
Cirrata Group and Beat Capital Partners Unite Under the Octave Brand as Octave Partners and Octave Ventures, RespectivelyAmbac Financial Group, Inc. (NYSE:AMBC) today announces it has rebranded to Octave Specialty Group,
11-11 06:23
Ambac Financial Group (NYSE:AMBC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 600 percent decrease over losses of $(0.03) per share from
11-11 05:08
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
The latest announcement is out from Graphene Manufacturing Group Ltd ( ($TSE:GM...
10-13 21:08
An update from Ambac Financial ( ($AMBC) ) is now available. On September 29, 2...
09-30 05:29
Ambac Financial Group, Inc. ("Ambac") (NYSE: AMBC), an insurance holding company, today announced it has entered into a definitive agreement to acquire ArmadaCare, a leading supplemental health insurance program manager, from SiriusPoint Ltd.
09-30 05:08
Ambac Financial ( ($AMBC) ) just unveiled an update. On September 29, 2025, Amb...
09-30 04:50
SiriusPoint Ltd. has agreed to sell its wholly owned ArmadaCare supplemental health insurance program manager to Ambac Financial Group Inc. for $250 million. The sale is expected to close in the fourth quarter, subject to regulatory approvals. SiriusPoint will recognize a pre-tax gain of $220-230 million and will continue its capacity partnership with Armada until the end of 2030. The transaction values ArmadaCare at approximately 14x EBITDA, wit...
09-29 20:30